|
CSA2 Human, liver cancer |
| |
|
|
|
|
|
|
|
|
|
Age |
Sex |
Organ |
Diagnosis |
TNM |
Stage |
Months* |
|
1 |
41 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
2 |
52 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
3 |
56 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
4 |
37 |
M |
liver |
HCC |
T4NxM1 |
Ⅳ |
. |
|
5 |
32 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
6 |
57 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
7 |
65 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
8 |
72 |
M |
liver |
well & poorly differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
9 |
58 |
F |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
10 |
52 |
M |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
11 |
40 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
12 |
67 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
13 |
20 |
M |
liver |
well differentiated HCC |
T4N0M0 |
ⅢB |
. |
|
14 |
48 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
15 |
47 |
M |
liver |
HCC |
T1N0M0 |
Ⅰ |
. |
|
16 |
69 |
F |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
17 |
63 |
F |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
18 |
60 |
F |
liver |
poorly differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
19 |
66 |
F |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
20 |
64 |
M |
liver |
poorly differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
21 |
64 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
22 |
51 |
M |
liver |
moderately differentiated HCC |
T4N0M0 |
ⅢB |
. |
|
23 |
65 |
F |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
24 |
41 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
25 |
57 |
F |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
26 |
57 |
M |
liver |
moderately differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
27 |
50 |
M |
liver |
poorly differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
28 |
43 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
29 |
60 |
F |
liver |
poorly differentiated HCC |
T4N0M0 |
ⅢB |
. |
|
30 |
64 |
M |
liver |
moderately differentiated HCC |
T3N1M0 |
ⅢC |
. |
|
31 |
52 |
M |
liver |
moderately differentiated HCC |
T3N1M0 |
ⅢC |
. |
|
32 |
54 |
M |
liver |
moderately differentiated HCC |
T4NxM1 |
Ⅳ |
. |
|
33 |
56 |
M |
liver |
well differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
34 |
77 |
M |
liver |
moderately differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
35 |
38 |
M |
liver |
HCC |
T1NxM0 |
Ⅰ |
. |
|
36 |
75 |
M |
liver |
moderately differentiated HCC |
T2N0M1 |
Ⅳ |
. |
|
37 |
43 |
M |
liver |
moderately differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
38 |
72 |
M |
liver |
moderately differentiated HCC |
T4N1M0 |
ⅢC |
. |
|
39 |
60 |
F |
liver |
cholangiocarcinoma |
T2N0M0 |
Ⅱ |
. |
|
40 |
58 |
M |
liver |
cholangiocarcinoma |
T3N1M1 |
Ⅳ |
. |
|
41 |
51 |
M |
colon |
metastatic HCC |
M1 |
Ⅳ |
. |
|
42 |
62 |
M |
lung |
metastatic HCC |
M1 |
Ⅳ |
. |
|
43 |
61 |
M |
lung |
metastatic HCC |
M1 |
Ⅳ |
. |
|
44 |
60 |
M |
adrenal gland |
metastatic HCC |
M1 |
Ⅳ |
. |
|
45 |
47 |
M |
lumbar vertebra |
metastatic HCC from #35 |
. |
. |
22 |
|
46 |
75 |
M |
colon |
metastatic HCC from #36 |
. |
. |
0 |
|
47 |
43 |
M |
soft tissue |
metastatic HCC from #37 |
. |
. |
5 |
|
48 |
72 |
M |
lymph node |
metastatic HCC from #38 |
. |
. |
0 |
|
49 |
60 |
F |
soft tissue |
metastatic cholangiocarcinoma from #39 |
. |
. |
16 |
|
50 |
58 |
M |
lymph node |
metastatic cholangiocarcinoma from #40 |
. |
. |
0 |
|
51 |
57 |
M |
liver |
normal liver (adjacent to cancer, match of #6) |
. |
. |
. |
|
52 |
72 |
M |
liver |
normal liver (adjacent to cancer, match of #8) |
. |
. |
. |
|
53 |
58 |
F |
liver |
normal liver (adjacent to cancer, match of #9) |
. |
. |
. |
|
54 |
52 |
M |
liver |
normal liver (adjacent to cancer, match of #10) |
. |
. |
. |
|
55 |
67 |
M |
liver |
normal liver (adjacent to cancer, match of #12) |
. |
. |
. |
|
56 |
32 |
M |
liver |
normal liver (apart from cancer, match of #5) |
. |
. |
. |
|
57 |
63 |
F |
liver |
normal liver (apart from cancer, match of #17) |
. |
. |
. |
|
58 |
65 |
F |
liver |
normal liver (apart from cancer, match of #23) |
. |
. |
. |
|
59 |
57 |
F |
liver |
normal liver (apart from cancer, match of #25) |
. |
. |
. |
|
60 |
carbon |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
HCC: hepatocellular carcinoma |
|
|
|
|
|
*: interval between primary and metastatic cancer |
|
|
|
|
TNM Classification : Liver carcinoma (AJCC 6th Edition) |
|
|
|